Hashim Ahmed
@londonprostate1.bsky.social
Chair of Urology
Lead, Section of Specialty Surgery
Consultant Urological Surgeon
Imperial
London
www.imperialprostate.org
Lead, Section of Specialty Surgery
Consultant Urological Surgeon
Imperial
London
www.imperialprostate.org
Reposted by Hashim Ahmed
October 31, 2025 at 7:03 PM
Reposted by Hashim Ahmed
🧵[5/6]
💡 Got a new trial idea to improve outcomes for men with prostate cancer?
Use our form and submit your proposal
Deadline: 4pm, Fri 13 Feb
Applicants are encouraged to present their ideas and take part in the discussion at the next CRSG meeting.
prostatecanceruk.org/research/for...
💡 Got a new trial idea to improve outcomes for men with prostate cancer?
Use our form and submit your proposal
Deadline: 4pm, Fri 13 Feb
Applicants are encouraged to present their ideas and take part in the discussion at the next CRSG meeting.
prostatecanceruk.org/research/for...
UK Prostate Cancer Clinical Research Strategy Group
Keep up to date on the activities of the group, access forms and key dates.
prostatecanceruk.org
October 31, 2025 at 7:03 PM
🧵[5/6]
💡 Got a new trial idea to improve outcomes for men with prostate cancer?
Use our form and submit your proposal
Deadline: 4pm, Fri 13 Feb
Applicants are encouraged to present their ideas and take part in the discussion at the next CRSG meeting.
prostatecanceruk.org/research/for...
💡 Got a new trial idea to improve outcomes for men with prostate cancer?
Use our form and submit your proposal
Deadline: 4pm, Fri 13 Feb
Applicants are encouraged to present their ideas and take part in the discussion at the next CRSG meeting.
prostatecanceruk.org/research/for...
Reposted by Hashim Ahmed
🧵[4/6]
🌱 Early-career clinical researchers — your opportunity is here!
Apply for one of two CRSG observer roles to learn from leaders, connect nationally & grow your research career in prostate cancer.
Deadline: 4pm, Fri 16 Jan
🌱 Early-career clinical researchers — your opportunity is here!
Apply for one of two CRSG observer roles to learn from leaders, connect nationally & grow your research career in prostate cancer.
Deadline: 4pm, Fri 16 Jan
October 31, 2025 at 7:03 PM
🧵[4/6]
🌱 Early-career clinical researchers — your opportunity is here!
Apply for one of two CRSG observer roles to learn from leaders, connect nationally & grow your research career in prostate cancer.
Deadline: 4pm, Fri 16 Jan
🌱 Early-career clinical researchers — your opportunity is here!
Apply for one of two CRSG observer roles to learn from leaders, connect nationally & grow your research career in prostate cancer.
Deadline: 4pm, Fri 16 Jan
Reposted by Hashim Ahmed
🧵[3/6]
👥 We’re recruiting Full Members!
Expertise wanted in:
🧬 Pathology
🏥 Primary care
💉 Research nursing
🩻 Radiology
Join us in shaping UK prostate cancer clinical research.
Deadline: 4pm, Fri 16 Jan
👥 We’re recruiting Full Members!
Expertise wanted in:
🧬 Pathology
🏥 Primary care
💉 Research nursing
🩻 Radiology
Join us in shaping UK prostate cancer clinical research.
Deadline: 4pm, Fri 16 Jan
October 31, 2025 at 7:03 PM
🧵[3/6]
👥 We’re recruiting Full Members!
Expertise wanted in:
🧬 Pathology
🏥 Primary care
💉 Research nursing
🩻 Radiology
Join us in shaping UK prostate cancer clinical research.
Deadline: 4pm, Fri 16 Jan
👥 We’re recruiting Full Members!
Expertise wanted in:
🧬 Pathology
🏥 Primary care
💉 Research nursing
🩻 Radiology
Join us in shaping UK prostate cancer clinical research.
Deadline: 4pm, Fri 16 Jan
Reposted by Hashim Ahmed
🧵[2/6]
The CRSG will shape clinical prostate cancer research by:
🔍 Identifying key research gaps
💪 Strengthening study design early
👏 Encouraging collaboration
🧑🎓 Mentoring early-career researchers
The CRSG will shape clinical prostate cancer research by:
🔍 Identifying key research gaps
💪 Strengthening study design early
👏 Encouraging collaboration
🧑🎓 Mentoring early-career researchers
October 31, 2025 at 7:03 PM
🧵[2/6]
The CRSG will shape clinical prostate cancer research by:
🔍 Identifying key research gaps
💪 Strengthening study design early
👏 Encouraging collaboration
🧑🎓 Mentoring early-career researchers
The CRSG will shape clinical prostate cancer research by:
🔍 Identifying key research gaps
💪 Strengthening study design early
👏 Encouraging collaboration
🧑🎓 Mentoring early-career researchers
Reposted by Hashim Ahmed
🧵[1/6]
📣 Big news for clinical prostate cancer researchers!
The NCRI Prostate Group has re-established as UK Prostate Cancer Clinical Research Strategy Group (CRSG) - a national hub for collaboration & innovation in prostate cancer research.
Learn more 👇
prostatecanceruk.org/research/for...
📣 Big news for clinical prostate cancer researchers!
The NCRI Prostate Group has re-established as UK Prostate Cancer Clinical Research Strategy Group (CRSG) - a national hub for collaboration & innovation in prostate cancer research.
Learn more 👇
prostatecanceruk.org/research/for...
October 31, 2025 at 7:00 PM
🧵[1/6]
📣 Big news for clinical prostate cancer researchers!
The NCRI Prostate Group has re-established as UK Prostate Cancer Clinical Research Strategy Group (CRSG) - a national hub for collaboration & innovation in prostate cancer research.
Learn more 👇
prostatecanceruk.org/research/for...
📣 Big news for clinical prostate cancer researchers!
The NCRI Prostate Group has re-established as UK Prostate Cancer Clinical Research Strategy Group (CRSG) - a national hub for collaboration & innovation in prostate cancer research.
Learn more 👇
prostatecanceruk.org/research/for...
Reposted by Hashim Ahmed
As debate grows over targeted #ProstateCancer screening, experts call for careful evaluation.
"We can often find disease that doesn't need to be treated and we end up causing harm" — Prof Hashim Ahmed (@londonprostate1.bsky.social)
@imperialsandc.bsky.social www.bbc.co.uk/news/article...
"We can often find disease that doesn't need to be treated and we end up causing harm" — Prof Hashim Ahmed (@londonprostate1.bsky.social)
@imperialsandc.bsky.social www.bbc.co.uk/news/article...
Rishi Sunak: Prostate cancer screening could 'save countless lives'
The former PM is among those in favour of targeted screening for men most at risk, but some medical experts are sceptical.
www.bbc.co.uk
October 15, 2025 at 11:20 AM
As debate grows over targeted #ProstateCancer screening, experts call for careful evaluation.
"We can often find disease that doesn't need to be treated and we end up causing harm" — Prof Hashim Ahmed (@londonprostate1.bsky.social)
@imperialsandc.bsky.social www.bbc.co.uk/news/article...
"We can often find disease that doesn't need to be treated and we end up causing harm" — Prof Hashim Ahmed (@londonprostate1.bsky.social)
@imperialsandc.bsky.social www.bbc.co.uk/news/article...
Reposted by Hashim Ahmed
Update of #IP7PACIFIC presented by @ajwlight.bsky.social at #AUA25 🇺🇸
This will be the first trial to provide definitive evidence comparing bpMRI vs mpMRI, alongside fusion vs cognitive biopsy
>1200 patients recruited across the UK - watch this space
This will be the first trial to provide definitive evidence comparing bpMRI vs mpMRI, alongside fusion vs cognitive biopsy
>1200 patients recruited across the UK - watch this space
April 29, 2025 at 8:28 AM
Update of #IP7PACIFIC presented by @ajwlight.bsky.social at #AUA25 🇺🇸
This will be the first trial to provide definitive evidence comparing bpMRI vs mpMRI, alongside fusion vs cognitive biopsy
>1200 patients recruited across the UK - watch this space
This will be the first trial to provide definitive evidence comparing bpMRI vs mpMRI, alongside fusion vs cognitive biopsy
>1200 patients recruited across the UK - watch this space
Reposted by Hashim Ahmed
April 29, 2025 at 4:09 PM
Reposted by Hashim Ahmed
New publication alert! 🚨
A clinician survey on the current practices within the prostate cancer diagnostic pathway in the United Kingdom - Uma Walters et al (Journal of Clinical Urology)
🔗 doi.org/10.1177/2051...
A clinician survey on the current practices within the prostate cancer diagnostic pathway in the United Kingdom - Uma Walters et al (Journal of Clinical Urology)
🔗 doi.org/10.1177/2051...
April 27, 2025 at 9:28 AM
New publication alert! 🚨
A clinician survey on the current practices within the prostate cancer diagnostic pathway in the United Kingdom - Uma Walters et al (Journal of Clinical Urology)
🔗 doi.org/10.1177/2051...
A clinician survey on the current practices within the prostate cancer diagnostic pathway in the United Kingdom - Uma Walters et al (Journal of Clinical Urology)
🔗 doi.org/10.1177/2051...
Reposted by Hashim Ahmed
5yr outcomes following Rezum for >80mL prostates presented by @ajwlight.bsky.social (on behalf of Yan Leung) #AUA25 🇺🇸
Take home message - 3 of 4 patients were free of retreatment by 5 years
Take home message - 3 of 4 patients were free of retreatment by 5 years
April 27, 2025 at 9:44 AM
5yr outcomes following Rezum for >80mL prostates presented by @ajwlight.bsky.social (on behalf of Yan Leung) #AUA25 🇺🇸
Take home message - 3 of 4 patients were free of retreatment by 5 years
Take home message - 3 of 4 patients were free of retreatment by 5 years
Reposted by Hashim Ahmed
Reposted by Hashim Ahmed
@ajwlight.bsky.social presents preliminary validation data on the #TARGET scoring system - good specificity and NPV for detecting GG2+ in-field disease
Watch this space for our definitive multi centre validation study! #AUA25 🇺🇸
Watch this space for our definitive multi centre validation study! #AUA25 🇺🇸
April 27, 2025 at 9:49 AM
@ajwlight.bsky.social presents preliminary validation data on the #TARGET scoring system - good specificity and NPV for detecting GG2+ in-field disease
Watch this space for our definitive multi centre validation study! #AUA25 🇺🇸
Watch this space for our definitive multi centre validation study! #AUA25 🇺🇸
Reposted by Hashim Ahmed
Building on our #IP8FLUORESCE study is #IB1LaserCOMPLETE - using ex vivo fluoresce confocal microscopy to establish muscle status in TURBT, presented by Archana Gopalakrishnan
Recruitment is under way - watch this space for results soon! #AUA25 🇺🇸
Recruitment is under way - watch this space for results soon! #AUA25 🇺🇸
April 28, 2025 at 9:00 AM
Building on our #IP8FLUORESCE study is #IB1LaserCOMPLETE - using ex vivo fluoresce confocal microscopy to establish muscle status in TURBT, presented by Archana Gopalakrishnan
Recruitment is under way - watch this space for results soon! #AUA25 🇺🇸
Recruitment is under way - watch this space for results soon! #AUA25 🇺🇸
Reposted by Hashim Ahmed
Powerful messages from @londonprostate1.bsky.social in the focal therapy plenary crossfire debate
Most intermediate risk cases are suitable, focal therapy is very effective, and the functional outcomes are superior. Surgeon training is crucial!
#AUA25 🇺🇸
Most intermediate risk cases are suitable, focal therapy is very effective, and the functional outcomes are superior. Surgeon training is crucial!
#AUA25 🇺🇸
April 27, 2025 at 9:39 AM
Powerful messages from @londonprostate1.bsky.social in the focal therapy plenary crossfire debate
Most intermediate risk cases are suitable, focal therapy is very effective, and the functional outcomes are superior. Surgeon training is crucial!
#AUA25 🇺🇸
Most intermediate risk cases are suitable, focal therapy is very effective, and the functional outcomes are superior. Surgeon training is crucial!
#AUA25 🇺🇸
Reposted by Hashim Ahmed
Pilot results from #IP2ATLANTA on novel cytoreductive treatments to the prostate & mets in de novo mHSPC presented by @londonprostate1.bsky.social #AUA25 🇺🇸
Take home - these treatments are safe and justified
Recruitment for the main trial has completed - PFS endpoint to be reported 2027
Take home - these treatments are safe and justified
Recruitment for the main trial has completed - PFS endpoint to be reported 2027
April 28, 2025 at 9:03 AM
Pilot results from #IP2ATLANTA on novel cytoreductive treatments to the prostate & mets in de novo mHSPC presented by @londonprostate1.bsky.social #AUA25 🇺🇸
Take home - these treatments are safe and justified
Recruitment for the main trial has completed - PFS endpoint to be reported 2027
Take home - these treatments are safe and justified
Recruitment for the main trial has completed - PFS endpoint to be reported 2027
Reposted by Hashim Ahmed
📢 Join us at @IP_London
We are recruiting a Clinical Research Fellow to join the #IP13AVIDITY team: RCT evaluating the role of PSMA PET/CT in directing treatment in patients w/ high-risk PCa (closing 15/04)
🔗 www.imperial.ac.uk/jobs/search-...
@londonprostate1.bsky.social @connorurol.bsky.social
We are recruiting a Clinical Research Fellow to join the #IP13AVIDITY team: RCT evaluating the role of PSMA PET/CT in directing treatment in patients w/ high-risk PCa (closing 15/04)
🔗 www.imperial.ac.uk/jobs/search-...
@londonprostate1.bsky.social @connorurol.bsky.social
Description
Please note that job descriptions are not exhaustive, and you may be asked to take on additional duties that align with the key responsibilities ment...
www.imperial.ac.uk
April 2, 2025 at 11:29 AM
📢 Join us at @IP_London
We are recruiting a Clinical Research Fellow to join the #IP13AVIDITY team: RCT evaluating the role of PSMA PET/CT in directing treatment in patients w/ high-risk PCa (closing 15/04)
🔗 www.imperial.ac.uk/jobs/search-...
@londonprostate1.bsky.social @connorurol.bsky.social
We are recruiting a Clinical Research Fellow to join the #IP13AVIDITY team: RCT evaluating the role of PSMA PET/CT in directing treatment in patients w/ high-risk PCa (closing 15/04)
🔗 www.imperial.ac.uk/jobs/search-...
@londonprostate1.bsky.social @connorurol.bsky.social
Reposted by Hashim Ahmed
💬 #TRANSFORM will look at new ways of screening to reduce false positives, reduce biopsy rates and reduce diagnosing low risk cancers whilst finding more high risk cancers that need treating.
@londonprostate1.bsky.social @prostatecanceruk.bsky.social @nihr.bsky.social
www.lbc.co.uk/opinion/view...
@londonprostate1.bsky.social @prostatecanceruk.bsky.social @nihr.bsky.social
www.lbc.co.uk/opinion/view...
I treat prostate cancer every day – now I'm launching a study that could transform screening and save lives
The debate on screening for prostate cancer has been raging for over two decades.
www.lbc.co.uk
March 28, 2025 at 11:14 AM
💬 #TRANSFORM will look at new ways of screening to reduce false positives, reduce biopsy rates and reduce diagnosing low risk cancers whilst finding more high risk cancers that need treating.
@londonprostate1.bsky.social @prostatecanceruk.bsky.social @nihr.bsky.social
www.lbc.co.uk/opinion/view...
@londonprostate1.bsky.social @prostatecanceruk.bsky.social @nihr.bsky.social
www.lbc.co.uk/opinion/view...
Reposted by Hashim Ahmed
Great to see Professor Hashim Ahmed @londonprostate1.bsky.social talking @nickferrarilbc.bsky.social through his PSA blood test this morning, and sharing why the TRANSFORM trial is vital for finding the best way to screen men for #ProstateCancer.
prostatecanceruk.org/research/tra...
prostatecanceruk.org/research/tra...
💬 #TRANSFORM will look at new ways of screening to reduce false positives, reduce biopsy rates and reduce diagnosing low risk cancers whilst finding more high risk cancers that need treating.
@londonprostate1.bsky.social @prostatecanceruk.bsky.social @nihr.bsky.social
www.lbc.co.uk/opinion/view...
@londonprostate1.bsky.social @prostatecanceruk.bsky.social @nihr.bsky.social
www.lbc.co.uk/opinion/view...
I treat prostate cancer every day – now I'm launching a study that could transform screening and save lives
The debate on screening for prostate cancer has been raging for over two decades.
www.lbc.co.uk
March 28, 2025 at 12:11 PM
Great to see Professor Hashim Ahmed @londonprostate1.bsky.social talking @nickferrarilbc.bsky.social through his PSA blood test this morning, and sharing why the TRANSFORM trial is vital for finding the best way to screen men for #ProstateCancer.
prostatecanceruk.org/research/tra...
prostatecanceruk.org/research/tra...
Two weeks to go!
Imperial Prostate Masterclass
In association with Focal Therapy Society
@ip-london.bsky.social
www.imperialprostatemasterclass.org
Imperial Prostate Masterclass
In association with Focal Therapy Society
@ip-london.bsky.social
www.imperialprostatemasterclass.org
March 27, 2025 at 11:02 PM
Two weeks to go!
Imperial Prostate Masterclass
In association with Focal Therapy Society
@ip-london.bsky.social
www.imperialprostatemasterclass.org
Imperial Prostate Masterclass
In association with Focal Therapy Society
@ip-london.bsky.social
www.imperialprostatemasterclass.org
Reposted by Hashim Ahmed
#IP2ATLANTA RCT pilot result #EAU25 🇪🇸
🔬 9 in 10 patients have a viable prostate tumour despite ADT+ARTA/Doce
🚦Early signal in prostate cancer mortality for cytoreductive arms
📈 Surgery, radiotherapy or ablation + SABR safe - Recruited (n=433) PFS exp.2027!
@connorurol.bsky.social
🔬 9 in 10 patients have a viable prostate tumour despite ADT+ARTA/Doce
🚦Early signal in prostate cancer mortality for cytoreductive arms
📈 Surgery, radiotherapy or ablation + SABR safe - Recruited (n=433) PFS exp.2027!
@connorurol.bsky.social
March 24, 2025 at 12:57 PM
#IP2ATLANTA RCT pilot result #EAU25 🇪🇸
🔬 9 in 10 patients have a viable prostate tumour despite ADT+ARTA/Doce
🚦Early signal in prostate cancer mortality for cytoreductive arms
📈 Surgery, radiotherapy or ablation + SABR safe - Recruited (n=433) PFS exp.2027!
@connorurol.bsky.social
🔬 9 in 10 patients have a viable prostate tumour despite ADT+ARTA/Doce
🚦Early signal in prostate cancer mortality for cytoreductive arms
📈 Surgery, radiotherapy or ablation + SABR safe - Recruited (n=433) PFS exp.2027!
@connorurol.bsky.social
Reposted by Hashim Ahmed
It’s a big last day at #EAU25 for our team! 🇪🇸
@connorurol.bsky.social - 2x #IP2ATLANTA pilot study results (12:00)
Mr Chase Ng - #RAPID 5-yr follow-up for negative biopsy patients (12:05)
Mr Nikhil Mayor - #IP8FLUORESCE late breaking results (12:15)
@connorurol.bsky.social - 2x #IP2ATLANTA pilot study results (12:00)
Mr Chase Ng - #RAPID 5-yr follow-up for negative biopsy patients (12:05)
Mr Nikhil Mayor - #IP8FLUORESCE late breaking results (12:15)
March 24, 2025 at 9:13 AM
It’s a big last day at #EAU25 for our team! 🇪🇸
@connorurol.bsky.social - 2x #IP2ATLANTA pilot study results (12:00)
Mr Chase Ng - #RAPID 5-yr follow-up for negative biopsy patients (12:05)
Mr Nikhil Mayor - #IP8FLUORESCE late breaking results (12:15)
@connorurol.bsky.social - 2x #IP2ATLANTA pilot study results (12:00)
Mr Chase Ng - #RAPID 5-yr follow-up for negative biopsy patients (12:05)
Mr Nikhil Mayor - #IP8FLUORESCE late breaking results (12:15)